chrX-67546514-TGGCGGCGGCGGCGGC-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000044.6(AR):​c.1406_1420delGCGGCGGCGGCGGCG​(p.Gly469_Gly473del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00802 in 552,271 control chromosomes in the GnomAD database, including 427 homozygotes. There are 995 hemizygotes in GnomAD. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G469G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0090 ( 7 hom., 156 hem., cov: 0)
Exomes 𝑓: 0.0078 ( 420 hom. 839 hem. )

Consequence

AR
NM_000044.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.29

Publications

6 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-67546514-TGGCGGCGGCGGCGGC-T is Benign according to our data. Variant chrX-67546514-TGGCGGCGGCGGCGGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 434259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0511 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.1406_1420delGCGGCGGCGGCGGCG p.Gly469_Gly473del disruptive_inframe_deletion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.1406_1420delGCGGCGGCGGCGGCG p.Gly469_Gly473del disruptive_inframe_deletion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.00903
AC:
750
AN:
83037
Hom.:
7
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00577
Gnomad ASJ
AF:
0.00270
Gnomad EAS
AF:
0.00971
Gnomad SAS
AF:
0.00328
Gnomad FIN
AF:
0.00168
Gnomad MID
AF:
0.0205
Gnomad NFE
AF:
0.00267
Gnomad OTH
AF:
0.0189
GnomAD2 exomes
AF:
0.0106
AC:
397
AN:
37570
AF XY:
0.00539
show subpopulations
Gnomad AFR exome
AF:
0.162
Gnomad AMR exome
AF:
0.0225
Gnomad ASJ exome
AF:
0.00128
Gnomad EAS exome
AF:
0.0451
Gnomad FIN exome
AF:
0.00224
Gnomad NFE exome
AF:
0.00819
Gnomad OTH exome
AF:
0.0203
GnomAD4 exome
AF:
0.00784
AC:
3678
AN:
469230
Hom.:
420
AF XY:
0.00725
AC XY:
839
AN XY:
115712
show subpopulations
African (AFR)
AF:
0.0422
AC:
554
AN:
13140
American (AMR)
AF:
0.0148
AC:
125
AN:
8439
Ashkenazi Jewish (ASJ)
AF:
0.00276
AC:
26
AN:
9430
East Asian (EAS)
AF:
0.0544
AC:
741
AN:
13630
South Asian (SAS)
AF:
0.00650
AC:
93
AN:
14314
European-Finnish (FIN)
AF:
0.00295
AC:
62
AN:
20997
Middle Eastern (MID)
AF:
0.0117
AC:
15
AN:
1284
European-Non Finnish (NFE)
AF:
0.00509
AC:
1872
AN:
367792
Other (OTH)
AF:
0.00940
AC:
190
AN:
20204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.592
Heterozygous variant carriers
0
44
88
133
177
221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00904
AC:
751
AN:
83041
Hom.:
7
Cov.:
0
AF XY:
0.00939
AC XY:
156
AN XY:
16615
show subpopulations
African (AFR)
AF:
0.0244
AC:
527
AN:
21640
American (AMR)
AF:
0.00576
AC:
45
AN:
7817
Ashkenazi Jewish (ASJ)
AF:
0.00270
AC:
6
AN:
2222
East Asian (EAS)
AF:
0.00975
AC:
25
AN:
2564
South Asian (SAS)
AF:
0.00329
AC:
5
AN:
1521
European-Finnish (FIN)
AF:
0.00168
AC:
4
AN:
2379
Middle Eastern (MID)
AF:
0.0230
AC:
4
AN:
174
European-Non Finnish (NFE)
AF:
0.00267
AC:
115
AN:
43135
Other (OTH)
AF:
0.0186
AC:
20
AN:
1076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00600
Hom.:
327

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Apr 29, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AR: BS1 -

not specified Benign:1
Jan 11, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AR-related disorder Benign:1
Dec 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3
Mutation Taster
=199/1
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746853821; hg19: chrX-66766356; API